Aravive Inc., of Houston, appointed Fred Eshelman chair of its board. Gail McIntyre was named CEO and appointed to the board.
Azurrx Biopharma Inc., of New York, appointed Gregory Oakes to its board, effective April 13, 2020.
Hemostemix Inc., of Calgary, Alberta, appointed Loran Swanberg to its board and Christina Wu interim chief financial officer.
PDS Biotechnology Corp., of Princeton, N.J., appointed Ilian Iliev to its board.